Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Disease area: Interstitial lung diseases

Abstract

Background: Idiopathic Pulmonary Fibrosis ( IPF ) is a progressive disease with poor prognosis. Major comorbidities such as cardiovascular diseases have been described.Aim: To investigate the prevalence of chronic ischaemic heart disease ( IHD ) in IPF patients.Methods: 110 consecutive IPF patients (73M; mean age 66±7, range 27-84 years; never smokers 50, former smokers 41; current smokers 19) were prospectively studied. IPF diagnosis was made by current ATS guidelines. The diagnosis of IHD was considered on medical history and coronary angiograms or stress echo test.Results: 63 IPF patients (57.2%) (38M; mean age 65±8, range 45-82 years; 13current smokers, 26 former smokers ) were affected by ischemic heart disease. Pulmonary function test: FEV₁ 65±18% vs Th; FVC 63±15% vs Th; DLCO 37±13% vs Th and DLCO/VA75±10% vs Th.Conclusions. An increased prevalence of ischaemic heart disease in IPF patients was observed. The high IHD prevalence did not appear to be correlate with the IPF severity. Further studies are needed to investigate the clinical impact of IHD on interstitial lung disease.

Rating:

Share or cite this content

Citations should be made in the following way:
M. Martino, M. Lanza, M. D'Amato, G. Caccavo, G. Calabrese, C. Vitale, A. A. Stanziola (Naples, Italy). Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study. Eur Respir J 2014; 44: Suppl. 58, 4516

Member's Comments

No comment yet.

Related content which might interest you: Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Features of clinical cours of chronic obstructive pulmonary disease and ischemic heart disease in case of comorbidity Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Chronic obstructive pulmonary disease and myocardial infarction: Special aspects of clinical course in comorbid conditions Source: International Congress 2014 – Predictors Year: 2014 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction Source: International Congress 2014 – Comorbidities Year: 2014 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical presentations Year: 2014 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Characteristics of essential hypertension in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 Peripheral neuropathy in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Prevalence of chronic kidney disease (CKD) in the UK COPD population Source: International Congress 2014 – COPD exacerbations Year: 2014 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014